Lantidra (donislecel) in type 1 diabetes: An in‐depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA ‐approved allogeneic islet cell therapy
Year: 2025
Type: article
Source: Diabetic Medicine
DOI: 10.1111/dme.70168
Institution: Akdeniz University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416124086